Recently you received a lot information related to Brexit. The key question in that regard: what is the next most favorable step for your Pharma and Life Sciences business? The center of the discussion should still be the handling of your supply chain. Please find hereinafter some inputs in that regard from an UK, Ireland […]
Dear readers Hope you had a good start into 2019. As you may already gathered through the press the referendum for the Swiss Tax Bill and AHV-Financing (Steuervorlage und AHV-Finanzierung – STAF) has been launched with success. The respective popular vote will take place in spring, i.e. on 19 May 2019. A lot of pharma […]
My recommendation on your next steps: Choose a holistic approach in order to assess and possibly optimise the health of your value chain (tax, legal, regulatory, operational, digital etc.). Use “scientific” out of the box thinking, innovation and an efficient delivery model as the tools to success.
Are you a pharmaceutical company selling drugs outlined in the list of special drugs and therapies (“Spezialitätenliste”) in Switzerland? If yes, you could benefit from the following information in connection with Swiss VAT.